PGF and hypertensive disorder: Other algorithms have been developed to predict pregnancy-associated HTN using biomarkers such as placental growth factor (PlGF) and/or ultrasonographic uterine artery Doppler velocimetry, but this strategy can be challenging to introduce in routine clinical practice10.